Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.2 EUR | -4.38% | -8.90% | -51.15% |
16/04 | Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024 | |
16/04 | Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 18.19M 19.73M 1.64B | Sales 2025 * | 23.47M 25.46M 2.11B | Capitalization | 22.65M 24.57M 2.04B |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | 1M 1.08M 90.08M | EV / Sales 2024 * | 1.24 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.96 x |
P/E ratio 2024 * |
47.4
x | P/E ratio 2025 * |
11.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.1% |
Latest transcript on Marinomed Biotech AG
1 week | -8.90% | ||
Current month | -11.08% | ||
1 month | -16.81% | ||
3 months | -33.71% | ||
6 months | -56.19% | ||
Current year | -51.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 01/06/01 | |
Founder | 56 | 01/06/01 | |
Pascal Schmidt
DFI | Director of Finance/CFO | 52 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 01/08/01 | |
Brigitte Ederer
BRD | Director/Board Member | 68 | 21/18/21 |
Director/Board Member | - | 15/22/15 |
Date | Price | Change |
---|---|---|
24/24/24 | 14.2 | -4.38% |
23/24/23 | 14.85 | -1.33% |
22/24/22 | 15.05 | -2.27% |
21/24/21 | 15.4 | -4.05% |
20/24/20 | 16.05 | -0.93% |
Delayed Quote Börse Stuttgart, May 24, 2024 at 02:00 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.83% | 31.75B | |
+62.86% | 26.6B | |
-21.68% | 14.41B | |
-8.73% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- MARI Stock
- 93Z Stock